相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effect of azole antifungal therapy on vincristine toxicity in childhood acute lymphoblastic leukaemia
Rosalin M. van Schie et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Prolonged half-life of voriconazole in a CYP2C19 homozygous poor metabolizer receiving vincristine chemotherapy: avoiding a serious adverse drug interaction
Brad Moriyama et al.
MYCOSES (2011)
Risk of Azole-Enhanced Vincristine Neurotoxicity in Pediatric Patients With Hematological Malignancies: Old Problem - New Dilemma
Zoe Dorothea Pana et al.
PEDIATRIC BLOOD & CANCER (2011)
Pharmacokinetic/Pharmacodynamic Profile of Posaconazole
Yanjun Li et al.
CLINICAL PHARMACOKINETICS (2010)
Vincristine Induced Neurotoxicity in Cancer Patients
Sunil Gomber et al.
INDIAN JOURNAL OF PEDIATRICS (2010)
Clinically relevant drug interactions of current antifungal agents
Paul O. Gubbins et al.
MYCOSES (2010)
Severe Life Threatening Neurotoxicity in a Child With Acute Lymphoblastic Leukemia Receiving Posaconazole and Vincristine
Sandeep Jain et al.
PEDIATRIC BLOOD & CANCER (2010)
Itraconazole for invasive fungal infection with pediatric malignancies
Ryoji Kobayashi et al.
PEDIATRICS INTERNATIONAL (2010)
Management of Drug and Food Interactions with Azole Antifungal Agents in Transplant Recipients
Elizabeth Dodds-Ashley
PHARMACOTHERAPY (2010)
Lack of Effect of Ginkgo biloba on Voriconazole Pharmacokinetics in Chinese Volunteers Identified as CYP2C19 Poor and Extensive Metabolizers
He-Ping Lei et al.
ANNALS OF PHARMACOTHERAPY (2009)
Pharmacokinetics, metabolism and bioavailability of the triazole antifungal agent voriconazole in relation to CYP2C19 genotype
Ina Scholz et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Clinical Relevance of the Pharmacokinetic Interactions of Azole Antifungal Drugs with Other Coadministered Agents
Roger J. M. Bruggemann et al.
CLINICAL INFECTIOUS DISEASES (2009)
The CYP2C19 ultra-rapid metabolizer genotype influences the pharmacokinetics of voriconazole in healthy male volunteers
Guo Wang et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2009)
CYP2C19 Genotype Is a Major Factor Contributing to the Highly Variable Pharmacokinetics of Voriconazole
Johanna Weiss et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Posaconazole-increased Vincristine Neurotoxicity in a Child A Case Report
Celine Eiden et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2009)
Vincristine: Can Its Therapeutic Index Be Enhanced?
Andrew Moore et al.
PEDIATRIC BLOOD & CANCER (2009)
Vincristine Induced Peripheral Neuropathy Potentiated by Voriconazole in a Patient With Previously Undiagnosed CMT1X
Christopher C. Porter et al.
PEDIATRIC BLOOD & CANCER (2009)
Modification of vincristine dosing during concomitant azole therapy in adult acute lymphoblastic leukemia patients
Stephen Harnicar et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2009)
Treatment of aspergillosis: Clinical practice guidelines of the infectious diseases society of America
Thomas J. Walsh et al.
CLINICAL INFECTIOUS DISEASES (2008)
Itraconazole oral solution enhanced vincristine neurotoxicity in five patients with malignant lymphoma
Naoto Takahashi et al.
INTERNAL MEDICINE (2008)
Possible increase of the neurotoxicity of vincristine by the concurrent use of posaconazole in a young adult with leukemia
Elpis Mantadakis et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2007)
Itraconazole-related increased vincristine neurotoxicity -: Case report and review of literature
M Bermúdez et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2005)
Severe vincristine neurotoxicity with concomitant use of itraconazole
H Ariffin et al.
JOURNAL OF PAEDIATRICS AND CHILD HEALTH (2003)
Vincristine-itraconazole interaction: Cause for increasing concern
RK Sathiapalan et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2002)
Enhanced vincristine neurotoxicity from drug interactions: Case report and review of literature
RK Sathiapalan et al.
PEDIATRIC HEMATOLOGY AND ONCOLOGY (2001)
Itraconazole-enhanced vincristine neurotoxicity in a child with acute lymphoblastic leukemia
MR Jeng et al.
PEDIATRIC HEMATOLOGY AND ONCOLOGY (2001)
Effects of the antifungal agents on oxidative drug metabolism - Clinical relevance
K Venkatakrishnan et al.
CLINICAL PHARMACOKINETICS (2000)
分享论文
